Anti-MOGS monoclonal antibody

Pre-made anti-MOGS monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to MOGS/MOGS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1202-Ab-1/ GM-Tg-hg-IP1202-Ab-2Anti-Human MOGS monoclonal antibodyHuman
GM-Tg-rg-IP1202-Ab-1/ GM-Tg-rg-IP1202-Ab-2Anti-Rat MOGS monoclonal antibodyRat
GM-Tg-mg-IP1202-Ab-1/ GM-Tg-mg-IP1202-Ab-2Anti-Mouse MOGS monoclonal antibodyMouse
GM-Tg-cynog-IP1202-Ab-1/ GM-Tg-cynog-IP1202-Ab-2Anti-Cynomolgus/ Rhesus macaque MOGS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1202-Ab-1/ GM-Tg-felg-IP1202-Ab-2Anti-Feline MOGS monoclonal antibodyFeline
GM-Tg-cang-IP1202-Ab-1/ GM-Tg-cang-IP1202-Ab-2Anti-Canine MOGS monoclonal antibodyCanine
GM-Tg-bovg-IP1202-Ab-1/ GM-Tg-bovg-IP1202-Ab-2Anti-Bovine MOGS monoclonal antibodyBovine
GM-Tg-equg-IP1202-Ab-1/ GM-Tg-equg-IP1202-Ab-2Anti-Equine MOGS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1202-Ab-1/ GM-Tg-hg-IP1202-Ab-2; GM-Tg-rg-IP1202-Ab-1/ GM-Tg-rg-IP1202-Ab-2;
GM-Tg-mg-IP1202-Ab-1/ GM-Tg-mg-IP1202-Ab-2; GM-Tg-cynog-IP1202-Ab-1/ GM-Tg-cynog-IP1202-Ab-2;
GM-Tg-felg-IP1202-Ab-1/ GM-Tg-felg-IP1202-Ab-2; GM-Tg-cang-IP1202-Ab-1/ GM-Tg-cang-IP1202-Ab-2;
GM-Tg-bovg-IP1202-Ab-1/ GM-Tg-bovg-IP1202-Ab-2; GM-Tg-equg-IP1202-Ab-1/ GM-Tg-equg-IP1202-Ab-2
Products NameAnti-MOGS monoclonal antibody
Formatmab
Target NameMOGS
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-MOGS monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1202-Ag-1Recombinant multi-species MOGS/ CDG2B/ CWH41 protein


    Target information

    Target IDGM-IP1202
    Target NameMOGS
    Gene ID7841,57377,78947,708913,483104,101086221,516155,100069105
    Gene Symbol and Synonyms1810017N02Rik,CDG2B,CWH41,DER7,GCS1,MOGS
    Uniprot AccessionQ13724,O88941
    Uniprot Entry NameMOGS_HUMAN,MOGS_RAT
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000115275
    Target ClassificationN/A

    The target: MOGS, gene name: MOGS, also named as CDG2B, CWH41, DER7, GCS1. This gene encodes the first enzyme in the N-linked oligosaccharide processing pathway. The enzyme cleaves the distal alpha-1,2-linked glucose residue from the Glc(3)-Man(9)-GlcNAc(2) oligosaccharide precursor. This protein is located in the lumen of the endoplasmic reticulum. Defects in this gene are a cause of type IIb congenital disorder of glycosylation (CDGIIb). Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.